Group 1 - The core point of the article highlights that Yongying Fund's manager Ren Jie achieved a remarkable annual return of 233.29% for the Yongying Technology Smart A fund in 2025, breaking a 17-year record in the public fund industry [1] - The fund significantly reduced its equity investment from 91.59% in Q3 to 78.76% by the end of Q4 2025, reallocating assets to bank deposits and clearing out bond investments [2] - The top ten holdings of the Yongying Technology Smart A fund saw changes, with new additions including Dongshan Precision, Jingwang Electronics, Industrial Fulian, and Cambridge Technology, while previous holdings like Taicheng Light, Lanke Technology, and Shijia Light did not appear in the top ten [2][3] Group 2 - The fund manager emphasized a continued focus on global cloud computing investments, particularly in the optical communication and PCB sectors, while also acknowledging the potential for mean reversion after valuation expansion cycles [1][4] - The Yongying Hong Kong Stock Connect Technology Smart fund also underwent significant changes, with major reductions in holdings of Tencent Holdings and Bilibili-W, both exceeding 20% [5][7] - The performance of the Yongying Hong Kong Stock Connect Technology Smart A and C shares showed a net value growth rate of -22.02% and -22.14% respectively, underperforming their benchmarks by 7.88 and 8.00 percentage points [7]

Group 1 - The core viewpoint of the article highlights that several high-performing public funds have increased their equity asset positions in Q2, focusing on structural opportunities in the technology and pharmaceutical sectors [1][2]. - As of July 16, multiple top-performing funds have reported significant increases in their equity allocations, with the Longcheng Pharmaceutical Industry Selected Mixed Fund achieving a net value growth rate of 75.18% in the first half of the year, alongside a 9.3-fold increase in asset scale [2][3]. - The stock investment ratio of the Longcheng Pharmaceutical Fund rose from 72.48% at the end of Q1 to 75.89% at the end of Q2, indicating a strategic shift towards higher equity exposure [2]. Group 2 - Fund managers have concentrated their adjustments towards the technology and pharmaceutical sectors, with notable shifts in holdings among top stocks, such as the transition of Yongying Technology's focus from "cloud computing and data centers" to the "global cloud computing industry" [3][4]. - Analysts suggest that in a structural market, actively managed equity funds can leverage stock selection advantages to achieve excess returns, particularly in high-growth sectors like artificial intelligence and robotics [4]. - Looking ahead, fund managers maintain an optimistic outlook for Q3, with expectations for innovation in pharmaceuticals and advancements in cloud computing, indicating a proactive investment strategy [4][5].